BC Week In Review | Oct 24, 2011
Financial News

TPP Global Development financial update

TPP Global Development and the University of Dundee (Dundee, U.K.) partnered to establish the Target Development Fund to invest in early stage drug discovery projects over the next two years. Financial details were not disclosed....
BC Week In Review | Apr 4, 2011
Company News

TPP Global Development, University of Aberdeen deal

TPP partnered with the university to develop IP related to nervous system disorders, inflammatory diseases and cancer over five years. TPP said the IP is still in preclinical development. Further terms were not disclosed. TPP...
BC Week In Review | Sep 6, 2010
Company News

TPP Global Development, University of Edinburgh deal

The partners will develop undisclosed preclinical IP from the university under a five-year research agreement. The partners will focus on nervous system disorders, immunology, inflammation and cancer. Further terms were not disclosed. TPP Global Development...
BC Innovations | Jun 3, 2010
Strategy

Filling the gap

Although a growing number of universities and research centers are taking steps to incubate translatable early-stage research, 1,2 the vast majority of institutions have yet to address the gap that exists between their discoveries and...
BC Week In Review | May 24, 2010
Financial News

TPP Global Development completes venture financing

TPP Global Development Ltd. , Edinburgh, U.K.   Business: Neurology, Cancer, Infectious   Date completed: 5/19/10   Type: Venture financing   Raised: £9.6 million ($13.9 million)   Investors: Scottish Enterprise; and other investors  ...
BC Extra | May 20, 2010
Financial News

TPP raises L9.6 million

TPP Global Development Ltd. (Edinburgh, U.K.) raised L9.6 million ($13.9 million) in a series A round. TPP said a group of investors, including new investor Scottish Enterprise, participated. TPP plans to develop early stage preclinical...
Items per page:
1 - 6 of 6
BC Week In Review | Oct 24, 2011
Financial News

TPP Global Development financial update

TPP Global Development and the University of Dundee (Dundee, U.K.) partnered to establish the Target Development Fund to invest in early stage drug discovery projects over the next two years. Financial details were not disclosed....
BC Week In Review | Apr 4, 2011
Company News

TPP Global Development, University of Aberdeen deal

TPP partnered with the university to develop IP related to nervous system disorders, inflammatory diseases and cancer over five years. TPP said the IP is still in preclinical development. Further terms were not disclosed. TPP...
BC Week In Review | Sep 6, 2010
Company News

TPP Global Development, University of Edinburgh deal

The partners will develop undisclosed preclinical IP from the university under a five-year research agreement. The partners will focus on nervous system disorders, immunology, inflammation and cancer. Further terms were not disclosed. TPP Global Development...
BC Innovations | Jun 3, 2010
Strategy

Filling the gap

Although a growing number of universities and research centers are taking steps to incubate translatable early-stage research, 1,2 the vast majority of institutions have yet to address the gap that exists between their discoveries and...
BC Week In Review | May 24, 2010
Financial News

TPP Global Development completes venture financing

TPP Global Development Ltd. , Edinburgh, U.K.   Business: Neurology, Cancer, Infectious   Date completed: 5/19/10   Type: Venture financing   Raised: £9.6 million ($13.9 million)   Investors: Scottish Enterprise; and other investors  ...
BC Extra | May 20, 2010
Financial News

TPP raises L9.6 million

TPP Global Development Ltd. (Edinburgh, U.K.) raised L9.6 million ($13.9 million) in a series A round. TPP said a group of investors, including new investor Scottish Enterprise, participated. TPP plans to develop early stage preclinical...
Items per page:
1 - 6 of 6